Lower Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 (FGF21) Ratios and Placental FGF21 Production in Gestational Diabetes

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Tan, Bee K ^a   Sivakumar, Kavitha ^a   Bari, Muhammad F ^a   Vatish, Manu ^b   Randeva, Harpal S ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; FIBROBLAST GROWTH FACTOR; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FATTY ACID BLOOD LEVEL; FEMALE; FETUS DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; MATERNAL DISEASE; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY DIABETES MELLITUS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION; BLOOD; CEREBROSPINAL FLUID; METABOLISM; MIDDLE AGED; PREGNANCY;

ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; PLACENTA; PREGNANCY;

EID: 84878653151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065254     Document Type: Article

References (27)

1. Chen J, Tan B, Karteris E, Zervou S, Digby J, et al. (2006) Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 49: 1292-1302.
2. Salihu HM, Mbah AK, Alio AP, Kornosky JL, Bruder K, et al. (2009) Success of programming fetal growth phenotypes among obese women. Obstet Gynecol 114: 333-339.
3. Baptiste-Roberts K, Barone BB, Gary TL, Golden SH, Wilson LM, et al. (2009) Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 122: 207-214.
4. Agarwal MM, Dhatt GS, Punnose J, Koster G, (2005) Gestational diabetes: dilemma caused by multiple international diagnostic criteria. Diabet Med 22: 1731-1736.
5. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, et al. (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352: 2477-2486.
6. Chu SY, Bachman DJ, Callaghan WM, Whitlock EP, Dietz PM, et al. (2008) Association between obesity during pregnancy and increased use of health care. N Engl J Med 358: 1444-1453.
7. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J, (2003) Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 133: 1674S-1683S.
8. Pathmaperuma AN, Mana P, Cheung SN, Kugathas K, Josiah A, et al. (2010) Fatty acids alter glycerolipid metabolism and induce lipid droplet formation, syncytialisation and cytokine production in human trophoblasts with minimal glucose effect or interaction. Placenta 31: 230-239.
9. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, et al. (2005) FGF-21 as a novel metabolic regulator. J Clin Invest 115: 1627-1635.
10. Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, et al. (2008) Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57: 1246-1253.
11. Gälman C, Lundåsen T, Kharitonenkov A, Bina HA, Eriksson M, et al. (2008) The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab 8: 169-174.
12. Li L, Yang G, Ning H, Yang M, Liu H, et al. (2008) Plasma FGF-21 levels in type 2 diabetic patients with ketosis. Diabetes Res Clin Pract 82: 209-213.
13. Li K, Li L, Yang M, Zong H, Liu H, et al. (2009) Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus. Eur J Endocrinol 161: 391-395.
14. Lin Z, Zhou Z, Liu Y, Gong Q, Yan X, et al. (2011) Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese. PLoS One 6: e18398.
15. Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, et al. (2008) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149: 6018-6027.
16. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, et al. (2007) Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab 5: 181-194.
17. Hsuchou H, Pan W, Kastin AJ, (2007) The fasting polypeptide FGF21 can enter brain from blood. Peptides 28: 2382-2386.
18. Sarruf DA, Thaler JP, Morton GJ, German J, Fischer JD, et al. (2010) Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 59: 1817-1824.
19. Tan BK, Hallschmid M, Adya R, Kern W, Lehnert H, et al. (2011) Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity. Diabetes 60: 2758-2762.
20. Butte NF, (2000) Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 71: 1256S-1261S.
21. Lappas M, Yee K, Permezel M, Rice GE, (2005) Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol 186: 457-465.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
23. Simán CM, Sibley CP, Jones CJ, Turner MA, Greenwood SL, (2001) The functional regeneration of syncytiotrophoblast in cultured explants of term placenta. Am J Physiol Regul Integr Comp Physiol 280: R1116-R1122.
24. Yamashita T, Yoshioka M, Itoh N, (2000) Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 277: 494-498.
25. Nam SY, Kratzsch J, Kim KW, Kim KR, Lim SK, et al. (2001) Cerebrospinal fluid and plasma concentrations of leptin, NPY, and alpha-MSH in obese women and their relationship to negative energy balance. J Clin Endocrinol Metab 86: 4849-4853.
26. Smirnakis KV, Martinez A, Blatman KH, Wolf M, Ecker JL, et al. (2005) Early pregnancy insulin resistance and subsequent gestational diabetes mellitus. Diabetes Care 28: 1207-1208.
27. Mørkrid K, Jenum AK, Sletner L, Vårdal MH, Waage CW, et al. (2012) Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes. Eur J Endocrinol 167: 579-588.